Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies.

With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies.

At Minaris, we are creating cell therapy miracles together. 

Minaris Regenerative Medicine is wholly owned by the Resonac Group.

Biotechnology

Life Sciences

Manufacturing

Medical Devices

Minaris Regenerative Medicine

Hiroto Bando

Marjorie Whipple

Eric Powers

Jennifer Diminni

Deborah Gardner

Christine Molokwu

Helmut Lerch

Renate Sporrer

William Burckardt

Takuya Muramoto

Prakash Manwani

The Business Development Team at Minaris Regenerative Medicine focuses on identifying and establishing strategic partnerships and opportunities to drive the company's growth in the cell and gene therapy sector. This team aligns market trends and client needs with Minaris' service offerings, manages relationships with key stakeholders, and collaborates across regions to expand market presence and secure new business ventures.

Business Development Team

Leadership Team

Quality Control and Assurance

Human Resources

Business Development Team

About

Team members

Other teams at Minaris Regenerative Medicine

Leadership Team

Quality Control and Assurance

Human Resources